Natalie Holles is the founder of Third Harmonic Bio. Third Harmonic Bio has raised $155M in total funding. Latest round: Series B. Backed by Atlas Venture.
Natalie Holles is the CEO and President of Third Harmonic Bio, a clinical-stage biotech company founded in 2019 to develop therapies for allergy and inflammation. She previously served as CEO of Audentes Therapeutics until its acquisition by Astellas Pharma. Holles led Third Harmonic Bio through its Series B financing.
Full founder directory · Investor directory · Company funding database · Fundraising library